Abbott Laboratories (NYSE:ABT): The Formidable Pharmaceutical Giant

Boston, MA 04/16/2014 (wallstreetpr) – Abbott Laboratories (NYSE:ABT) has recently hived off its research based proprietary pharmaceuticals business to give birth to a new company called AbbVie. In a bid to increase its expertise and diversity, ABT also acquired Optimedica Corporation and IDEV Technologies. The company has recently enrolled three clinical trials in a bid […]